| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -8.31% | -1.04% | -7.26% | -9.10% | — |
| 14d | 4 | +75.00% | -8.56% | -0.42% | -8.14% | -13.97% | — |
| 30d | 4 | +50.00% | +6.35% | -0.50% | +6.85% | -7.11% | — |
| 60d | 4 | +75.00% | -7.98% | -0.32% | -7.66% | -13.81% | — |
| 90d | 4 | +75.00% | -18.85% | -1.19% | -17.67% | -28.38% | — |
| 180d | 4(1 pending) | +66.67% | -40.30% | +7.51% | -47.81% | -69.36% | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LYEL LYELL IMMUNOPHARMA, INC. | SALE VP, Corporate Controller | 217 | $18.91 | $4.1K | 15,420 | May 11, 2026 | Jun 15, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | PURCHASEGRANT Stock grant | 8,750 | — | — | 15,891 | Feb 10, 2026 | Feb 11, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE VP, Corporate Controller | 254 | $23.12 | $5.9K | 15,637 | Feb 10, 2026 | Feb 11, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE VP, Corporate Controller | 936 | $32.32 | $30.3K | 7,141 | Dec 30, 2025 | Jan 6, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE VP, Corporate Controller | 1,136 | $38.67 | $43.9K | 8,077 | Dec 24, 2025 | Jan 6, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE VP, Corporate Controller | 239 | $16.10 | $3.8K | 9,213 | Nov 10, 2025 | Nov 12, 2025 ↗ | View → |